Problem 2The average cost of hospital care for COVID-19 ranges from $51,000 to $78,000, based on severity.Consider the following samples provided by Hospital A, Hospital B, and the healthcare industry(American Hospital Association or AHA) for severity level AIX.Hospital ASeverity Level A1XSeverity Level A1xSeverity Level: A1XSeverity Level: A1xSeverity Level: A1xHospital BSeverity Level A1xSeverity Level A1xSeverity Level: A1xSeverity Level: A1XSeverity Level: A1xAHA (Benchmark)Severity Level A1xSeverity Level A1XSeverity Level: A1xSeverity Level: A1XSeverity Level: A1XCost $57,72451,12754,93050,28266,76171,13875,21069,10571,13876,01667,07357,31770,32554,47250,813a. Perform a cost effectiveness analysis on Hospital A. Use a 95% confidence level (alpha= 5%). Hint: useregression analysis to assess deviation from the benchmark (AHA average cost).b. Perform a cost effectiveness analysis on Hospital B. Use a 95% confidence level (alpha= 5%). Hint: useregression analysis to assess deviation from the benchmark (AHA average cost).

Cost Effectiveness Analysis Is referred to as a form of economic analysis which compares the…

The average cost of hospital care for COVID-19 ranges from $51,000 to $78,000, based on severity. Consider the following samples provided by Hospital A, Hospital B, and the healthcare industry (American Hospital Association or AHA) for severity level AIX.

The average cost of hospital care for COVID-19 ranges from $51,000 to $78,000, based on severity. Consider the following samples provided by Hospital A, Hospital B, and the healthcare industry (American Hospital Association or AHA) for severity level AIX.

EBK HEALTH ECONOMICS AND POLICY

7th Edition

ISBN:9781337668279

Author:Henderson

Publisher:Henderson

Chapter12A: Appendix 12a Changing Demographics: The Aging Of America

Section: Chapter Questions

Problem 4QAP

See similar textbooks

Similar questions

What is the term for a measure of Public Health directly related to the value of human life and the economic implications of the loss of individuals in a society
Getitall, the CEO of Gooddrug LLC claimed that in the US, drug companies should receive a patent of 100 years for each drug they develop. this allows them a prolonged llegal monopoly on the sale of that drug, provide better incentives to innovate and help consumer pay stable prices. Jane, the FDA consultant strongly disagree with that statement. Give reasons related to consumers, patients, and the market to support Jane's claim End PrtScn F8 Home F9 F10 F3 F4 F5 F6 F7 2$ & 7 9- 6
Please refernece attachment. See image below.
No need explanation just draw a extensive form for me.
Compared to fee-for-service payment, what are theadvantages and disadvantages of payment based ondiagnosis-related groups?
6. There is no safe hobby, is there? What could be healthier than gardening? Apparently, not-gardening! Researchers conducted a case-control study with current prevalence of low back pain (outcome) and frequent gardening (exposure). Researchers stratified the data by age. Current prevalent low back pain was defined based on the reporting of at least one episode of low back pain during the past month. Table A shows the age stratified results of the study. Frequent Gardening Low Back Pain (LBP) Yes LBP No LBP Age < 65 years Yes 90 315 No 35 210 Age 2 65 years Yes 65 25 No 60 45 a. Using the data in Table A, calculate the unadjusted (crude) exposure odds ratio. (Hints: unadjusted / crude means we do not consider age. Note we are asking for the exposure OR. )|
Wokwkwkekdkxkdkxd
A consumer advocate researches the length of life between two brands of refrigerators, Brand A and Brand B. He collects data (measured in years) on the longevity of 40 refrigerators for Brand A and repeats the sampling for Brand B. A portion of the data is shown in the accompanying table. (You may find it useful to reference the appropriate table: z table or t table) Brand A Brand B 16 16 14 20 18 17 Click here for the Excel Data File Assume that u, is the mean longevity for Brand A and u, is the mean longevity for Brand B. a. Specify the competing hypotheses to test whether the average length of life differs between the two brands. O Ho: 41 - H2 = 0; HẠ: H1 - H2 # 0 O Ho: H1 - H2 z 0; HẠ: H1 – 42 0 b-1. Calculate the value of the test statistic. Assume that o2 = 4.4 and og? = 5.2. (Negative value should be indicated by a minus sign. Round final answer to 2 decimal places.) Test statistic
2. The CDC released the following data for the US population in its 2013 Vital Statistics report. Calculate the mortality rate for each age interval and add it to the table above. Then, below, describe the trends in adult and childhood mortality in the United States in 2013. Age interval Number dying in age interval Number surviving at beginning of age interval Mortality Rate (per 1000) 0-10 756 100,000 11-20 292 99,244 21-30 890 98,953 31-40 1,234 98,164 41-50 2,457 96,811 51-60 5,564 94,352 61-70 10,479 88,788
Suppose you are currently (i.e. 2024) performing a cost-effectiveness analysis and you wish to include the cost per visit of a hospital admission for an acute ischemic stroke in a patient without major complications or comorbidities in your analysis. The Agency for Healthcare Research and Quality's HCUP National Inpatient Sample online database reports the following information for 2015: 2015 National Medicare-Severity Diagnosis Related Groups (MS-DRG): #063 Acute ischemic stroke w use of thrombolytic agent w/o cc/mcc Number Total number of discharges: N All discharges + Rate Rate of discharges per 100,000 persons 2.2 Length of stay LOS (length of stay), days (mean) 3.0 LOS (length of stay), days (median) 3.0 Hospital charges Charges, $ (mean) 63,243 Hospital costs Costs, $ (mean) 15,239 + Due to the transition from ICD-9-CM to ICD-10-CM in October 2015, these 2015 statistics were calculated using only quarter 1-3 data, and the statistics available are limited What would you use for…
Hi, please could you help me with 1 a ii and iii, and 1c.
Briefly Explain the differences between Rapid Upper Limb Assessment and Rapid Entire Body Assessment.